Aoxing Pharmaceutical Company, Inc. Financial Ratios — AOXG

Profitability (USD)

	2004 Y	2005 Y	2006 Y	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y
As of date	12/31/2004	12/31/2005	06/30/2006	06/30/2007	06/30/2008	06/30/2009	06/30/2010	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-6.52	-12.88	-15.94	8.4	-4.35	-1.45	-12.98	-31.34	-39.62	-21.12	12.06	3.77
Return on Capital (%)	- -	- -	- -	- -	95.62	- -	- -	- -	- -	- -	- -	- -	-6.32
Return on Invested Capital (%)	- -	- -	- -	- -	-10.18	- -	- -	- -	- -	- -	- -	- -	11.26
Gross Margin (%)	68.7	71.31	- -	46.43	45.72	42.57	61.72	49.97	60.24	57.87	45.64	77.67	75.95
EBITDA Margin (%)	1.75	5.5	- -	-39.85	-40.32	-17.04	-40.26	-55.68	-0.87	-50.19	-18.41	36.74	22.44
Operating Margin (%)	-12.6	-6.57	- -	-151.63	-50.66	-28.42	-58.6	-73	-14.14	-60.47	-26.18	34.13	19.26
Incremental Operating Margin (%)	- -	- -	57.78	- -	- -	- -	- -	- -	- -	- -	- -	94.42	-36.03
Pretax Margin (%)	-19.9	-26	- -	- -	51.62	-66.83	-14.84	-66.51	-195.2	-159.66	-67.78	12.22	8.93
Profit Margin (%)	-19.9	-26	- -	-200.12	51.62	-27.42	-13.61	-111.42	-194.49	-155.17	-64.49	21.56	6.38
Net Income to Common Margin (%)	-19.9	-26	- -	-200.12	51.62	-27.42	-13.61	-111.42	-194.49	-155.17	-64.49	21.56	6.38
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.26
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2004 Y	2005 Y	2006 Y	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y
As of date	12/31/2004	12/31/2005	06/30/2006	06/30/2007	06/30/2008	06/30/2009	06/30/2010	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016

Total Debt	- -	- -	11	15	18	20	15	12	15	27	32	32	25
ST Debt	- -	- -	3	8	10	12	9	9	12	14	25	30	25
LT Debt	- -	- -	8	7	8	8	6	4	3	13	8	1	- -
Total Debt/EBITDA	17.31	4.41	-18.99	-18.79	-6.46	-12.89	-6.03	-3.36	-219.52	-4.96	-13.78	3.4	3.51
Net Debt/EBITDA	10.49	4.16	-18.99	-16.84	-5.91	-12.06	-4.41	-2.62	-167.18	-4.22	-12.79	2.82	2.56
Total Debt/EBIT	-2.4	-3.68	-12.26	-4.94	-5.14	-7.73	-4.14	-2.57	-13.43	-4.12	-9.69	3.66	4.09
Net Debt/EBIT	-1.45	-3.48	-12.26	-4.43	-4.71	-7.23	-3.03	-2	-10.23	-3.51	-8.99	3.04	2.98
EBITDA to Interest Expense	- -	- -	- -	- -	-1.13	-0.79	-1.01	-2.12	-0.04	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	-1.72	-1.95	-1.84	-2.91	-0.44	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	-1.42	-1.32	-1.48	-2.78	-0.62	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	3	2	2	2	2	- -	- -	- -	- -
Common Equity/Total Assets	-92.84	-104.13	-15.97	-21.98	-21.8	-25.95	-26.66	-41.09	-86.01	-139.89	-167.56	-109.89	-99.98
Long-Term Debt/Equity (%)	5.39	5.34	174.8	56.2	33.08	30.83	18.45	10.35	16.46	285.38	- -	13.61	- -
Long-Term Debt/Capital (%)	-5.49	-4.71	95.46	88.48	134.35	162.66	-652.38	-33.3	-14.61	-44.03	-22.74	-4.95	- -
Long-Term Debt/Total Assets (%)	4.75	4.61	43.93	22.39	14.83	13.39	10.85	6.62	7.76	32.92	19.7	2.58	- -
Total Debt/Equity (%)	7.11	7.19	246.67	118.71	73.14	79.73	43.26	34.89	72.64	588.26	-806.11	316.09	140.92
Total Debt/Capital (%)	-7.26	-6.34	134.71	186.89	297.02	420.72	-1,529.92	-112.27	-64.5	-90.76	-97.95	-115.02	-80.09
Total Debt/Total Assets (%)	6.28	6.21	61.99	47.28	32.79	34.62	25.45	22.3	34.26	67.86	84.87	59.97	45.3
Net Debt to Equity	4.31	6.8	246.66	106.36	66.92	74.57	31.65	27.14	55.32	500.82	-747.99	262.71	102.68
Net Debt/Capital (%)	-4.27	-5.97	134.72	207.87	363.62	540.78	-219.07	-69.86	-42.57	-68.09	-84.9	-80.05	-47.94
EBITDA	- -	- -	-1	-1	-3	-2	-2	-4	- -	-5	-2	9	7
EBITDA-CapEx	- -	- -	-1	-2	-4	-4	-4	-5	-1	-6	-3	7	7
Operating Income (Loss)	- -	- -	-1	-3	-4	-3	-4	-5	-1	-7	-3	9	6

Liquidity (USD)

API ChatGPT

	2004 Y	2005 Y	2006 Y	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y
As of date	12/31/2004	12/31/2005	06/30/2006	06/30/2007	06/30/2008	06/30/2009	06/30/2010	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016

Cash Ratio	0.36	0.04	- -	0.13	0.08	0.06	0.29	0.19	0.2	0.18	0.07	0.13	0.18
Current Ratio	0.65	0.36	0.03	0.17	0.28	0.17	0.66	0.5	0.51	0.55	0.32	0.51	0.71
Quick Ratio	0.58	0.29	- -	0.14	0.22	0.11	0.42	0.33	0.35	0.32	0.18	0.27	0.48
CFO/Avg Current Liab	- -	-0.28	-0.24	-0.12	-0.07	-0.03	-0.23	-0.19	-0.08	-0.41	-0.28	0.08	-0.01
Common Equity/Total Assets	-92.84	-104.13	-15.97	-21.98	-21.8	-25.95	-26.66	-41.09	-86.01	-139.89	-167.56	-109.89	-99.98
Long-Term Debt/Equity (%)	5.39	5.34	174.8	56.2	33.08	30.83	18.45	10.35	16.46	285.38	- -	13.61	- -
Long-Term Debt/Capital (%)	-5.49	-4.71	95.46	88.48	134.35	162.66	-652.38	-33.3	-14.61	-44.03	-22.74	-4.95	- -
Long-Term Debt/Total Assets (%)	4.75	4.61	43.93	22.39	14.83	13.39	10.85	6.62	7.76	32.92	19.7	2.58	- -
Total Debt/Equity (%)	7.11	7.19	246.67	118.71	73.14	79.73	43.26	34.89	72.64	588.26	-806.11	316.09	140.92
Total Debt/Capital (%)	-7.26	-6.34	134.71	186.89	297.02	420.72	-1,529.92	-112.27	-64.5	-90.76	-97.95	-115.02	-80.09
Total Debt/Total Assets (%)	6.28	6.21	61.99	47.28	32.79	34.62	25.45	22.3	34.26	67.86	84.87	59.97	45.3
CFO/Total Liabilities	-14.01	-16.53	-5.46	-5.75	-3.17	-2	-16.56	-13.26	-5.57	-23.66	-18.37	7.04	-1.4
CFO/CapEx	-1.78	- -	- -	-0.96	-0.66	-0.29	-1.99	-1.95	-1.76	-18.93	-28.74	1.12	-4.54
Altman's Z-Score	-1.21	1.7	36.38	13.64	2.94	0.56	2.84	0.46	-1.25	-2.38	-2.85	0.56	0.03

Working Capital (USD)

API ChatGPT

	2004 Y	2005 Y	2006 Y	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y
As of date	12/31/2004	12/31/2005	06/30/2006	06/30/2007	06/30/2008	06/30/2009	06/30/2010	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016

Accounts Receivable Turnover	- -	13.16	- -	34.43	5.33	4.97	4.39	3.57	3.38	3.84	3.78	5.23	3.79
Days Sales Outstanding	- -	27.73	- -	10.6	68.42	73.48	83.18	102.38	107.97	95.16	96.46	69.79	96.27
Inventory Turnover	- -	14.06	- -	9.45	7.18	6.58	2.06	2.19	1.98	2.06	2.88	2.09	2.56
Days Inventory Outstanding	- -	25.97	- -	38.61	50.86	55.49	177.53	166.41	184.79	177.11	126.94	174.37	142.74
Accounts Payable Turnover	- -	3.43	-0.07	1.49	2.01	1.57	1.21	1.26	1.32	1.56	1.57	1.73	2.33
Accounts Payable Turnover Days	- -	106.51	-5,160.22	244.57	181.56	232.23	301.48	289.02	277.06	233.59	232.89	211.26	156.72
Cash Conversion Cycle	- -	-52.81	- -	-195.35	-62.28	-103.26	-40.76	-20.22	15.7	38.68	-9.49	32.9	82.3
Inventory to Cash Days	- -	1.77	- -	-28.01	17.56	17.99	-94.35	-64.03	-76.82	-81.95	-30.48	-104.57	-46.47
Inventories	- -	- -	- -	- -	1	1	2	1	2	3	2	3	3
Raw Materials	- -	- -	- -	- -	- -	- -	- -	1	- -	1	1	1	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	- -	1
Finished Goods	- -	- -	- -	- -	- -	- -	1	- -	1	1	1	2	1
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2004 Y	2005 Y	2006 Y	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y
As of date	12/31/2004	12/31/2005	06/30/2006	06/30/2007	06/30/2008	06/30/2009	06/30/2010	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016

Market Capitalization	- -	4	833	449	207	91	149	64	16	11	16	110	48
- Cash & Cash Equivalents	- -	- -	- -	2	2	1	4	3	4	4	2	5	7
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	-1	-1	-1	-2	-1	-1
+ Total Debt	- -	- -	11	15	18	20	15	12	15	27	32	32	25
Enterprise Value	- -	4	844	462	224	109	159	73	27	33	44	136	65
Total Capital	-5	-5	8	8	6	5	-1	-11	-24	-30	-33	-28	-32
Total Debt/Capital (%)	-7.26	-6.34	134.71	186.89	297.02	420.72	-1,529.92	-112.27	-64.5	-90.76	-97.95	-115.02	-80.09
Total Debt / EV	1.64	0.08	0.01	0.03	0.08	0.18	0.09	0.17	0.57	0.83	0.73	0.23	0.39
EV/Sales	0.18	2.91	- -	238.37	31.66	12.16	26.03	11.03	3.34	3.01	3.49	5.33	2.02
EV/EBITDA	10.53	52.9	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.49	9.02
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.61	10.5
EV/Cash Flow to Firm	- -	- -	- -	- -	145.83	488	- -	178.86	50.67	- -	- -	44.85	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	74.13	44.39	576.06	41.14	21.09	- -	- -	23.68	- -
Diluted Market Cap	- -	4	833	449	207	91	149	64	16	11	16	111	49
Diluted Enterprise Value	- -	4	844	462	224	109	159	73	27	33	44	136	67
EV per Share	0.89	15.63	42.16	23.05	9.08	2.64	3.49	1.58	0.55	0.65	0.89	2.15	0.89
TTM Sales	1	1	- -	2	7	9	6	7	8	11	13	25	32
TTM EBITDA	- -	- -	-1	-1	-3	-2	-2	-4	- -	-5	-2	9	7
TTM Operating Income	- -	- -	-1	-3	-4	-3	-4	-5	-1	-7	-3	9	6
TTM Cash Flow to Firm	- -	- -	- -	- -	2	- -	-2	- -	1	-8	-8	3	-1
TTM Free Cash Flow to Firm	- -	- -	- -	- -	3	2	- -	2	1	-8	-7	6	- -

Multiples (USD)

API ChatGPT

	2004 Y	2005 Y	2006 Y	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y
As of date	12/31/2004	12/31/2005	06/30/2006	06/30/2007	06/30/2008	06/30/2009	06/30/2010	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016

Price/Free Cash Flow	- -	-30.49	-1,134.06	10,276.69	411.55	57.2	-74.95	-49.45	-27.96	-1.36	-2.14	19.29	-117.6
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	15.61	10.5
Enterprise Value	- -	4	844	462	224	109	159	73	27	33	44	136	65
Low Price	- -	3.2	3.52	8.08	4.8	0.72	1.52	0.75	0.19	0.18	0.2	0.18	0.58
EV/Sales	0.18	2.91	- -	238.37	31.66	12.16	26.03	11.03	3.34	3.01	3.49	5.33	2.02
EV/EBITDA	10.53	52.9	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.49	9.02
Price/Earnings	- -	- -	- -	- -	56.71	- -	- -	- -	- -	- -	- -	20.1	23.24
Price/Earnings Average	- -	-7.86	-440.25	-162.76	115.02	-44.89	-132.17	-14.54	-1.62	-0.76	-1.89	9.41	38.1
Price/Earnings High	- -	-20.61	-2,075.37	-248.06	191.74	-154.57	-227.87	-22.63	-4.3	-1.48	-4.36	39.97	67.93
Price/Earnings Low	- -	-2.29	-46.59	-41.76	32.41	-12.1	-83.26	-4.72	-0.58	-0.54	-1.21	2.07	20.84
Price/Book Value	- -	-0.66	-290.05	-66.52	-16.91	-6.16	-9.55	-2.8	-0.41	-0.19	-0.25	-1.89	-0.85
Price/Book Value Average	- -	-0.5	-231.92	-93.52	-34.29	-7.48	-7.07	-4.69	-0.66	-0.23	-0.24	-0.89	-1.4
Price/Book Value High	- -	-1.32	-1,093.26	-142.54	-57.16	-25.74	-12.19	-7.3	-1.76	-0.45	-0.56	-3.77	-2.49
Price/Book Value Low	- -	-0.15	-24.54	-23.99	-9.66	-2.01	-4.45	-1.52	-0.24	-0.16	-0.16	-0.19	-0.76
Price/Tangible Book Value	- -	0.8	184.36	36.71	44.75	21.77	10.72	4.46	1.23	2.69	-3.5	11.53	2.96
Price/Tangible Book Value Average	- -	0.61	147.41	51.62	90.75	26.44	7.93	7.48	1.96	3.21	-3.41	5.4	4.85
Price/Tangible Book Value High	- -	1.59	694.9	78.67	151.28	91.05	13.68	11.64	5.22	6.25	-7.87	22.93	8.64
Price/Tangible Book Value Low	- -	0.18	15.6	13.24	25.57	7.13	5	2.43	0.71	2.28	-2.19	1.19	2.65
Price/Sales	- -	2.68	- -	231.66	29.27	10.14	24.3	9.66	1.97	0.99	1.25	4.33	1.48
Price/Sales Average	- -	2.04	- -	325.71	59.37	12.31	17.98	16.2	3.14	1.18	1.22	2.03	2.43
Price/Sales High	- -	5.36	- -	496.41	98.97	42.39	31.01	25.21	8.37	2.3	2.81	8.62	4.33
Price/Sales Low	- -	0.6	- -	83.56	16.73	3.32	11.33	5.25	1.13	0.84	0.78	0.45	1.33
Price/Cash Flow	- -	-30.49	-1,134.06	-422.65	-210.84	-141.06	-37.35	-24.05	-12.1	-1.29	-2.06	36.5	-89.54
Price/Cash Flow Average	- -	-23.26	-906.77	-594.25	-427.61	-171.3	-27.64	-40.3	-19.27	-1.53	-2.01	17.09	-146.81
Price/Cash Flow High	- -	-60.97	-4,274.53	-905.69	-712.83	-589.88	-47.66	-62.73	-51.35	-2.99	-4.64	72.58	-261.73
Price/Cash Flow Low	- -	-6.77	-95.96	-152.46	-120.48	-46.16	-17.41	-13.07	-6.96	-1.09	-1.29	3.75	-80.31
Price/Free Cash Flow Average	- -	-23.26	-906.77	14,448.85	834.69	69.46	-55.47	-82.87	-44.53	-1.62	-2.08	9.03	-192.81
Price/Free Cash Flow High	- -	-60.97	-4,274.53	22,021.49	1,391.42	239.19	-95.64	-128.99	-118.68	-3.16	-4.8	38.36	-343.75
Price/Free Cash Flow Low	- -	-6.77	-95.96	3,706.95	235.17	18.72	-34.94	-26.88	-16.08	-1.15	-1.34	1.98	-105.48
EV/Sales Average	0.18	2.27	- -	332.42	61.76	14.34	19.72	17.56	4.51	3.2	3.45	3.02	2.97
EV/Sales High	0.18	5.59	- -	503.12	101.36	44.42	32.74	26.58	9.74	4.32	5.05	9.61	4.87
EV/Sales Low	0.18	0.82	- -	90.27	19.11	5.34	13.06	6.62	2.51	2.86	3.02	1.44	1.87
EV/EBITDA Average	10.53	41.35	-1,153.77	-834.08	-153.18	-84.14	-48.98	-31.54	-521.58	-6.37	-18.76	8.22	13.24
EV/EBITDA High	10.53	101.63	-5,368.38	-1,262.39	-251.41	-260.66	-81.32	-47.73	-1,126.2	-8.6	-27.43	26.16	21.71
EV/EBITDA Low	10.53	14.99	-139.08	-226.51	-47.41	-31.36	-32.45	-11.89	-289.58	-5.69	-16.4	3.91	8.34
EV/EBIT Average	-1.46	-34.57	-745.11	-219.23	-121.91	-50.45	-33.64	-24.06	-31.92	-5.29	-13.19	8.85	15.42
EV/EBIT High	-1.46	-84.96	-3,466.9	-331.8	-200.09	-156.29	-55.86	-36.41	-68.91	-7.14	-19.29	28.16	25.29
EV/EBIT Low	-1.46	-12.54	-89.82	-59.53	-37.73	-18.8	-22.29	-9.07	-17.72	-4.72	-11.53	4.21	9.71
Last Price	- -	14.4	41.6	22.4	8.4	2.2	3.26	1.38	0.33	0.22	0.32	1.75	0.65
High Price	- -	28.8	156.8	48	28.4	9.2	4.16	3.6	1.38	0.5	0.72	3.48	1.9
Enterprise Value Average	- -	3	677	644	436	128	121	117	37	35	44	77	96
Enterprise Value High	- -	8	3,151	975	716	397	200	177	79	47	64	245	158
Enterprise Value Low	- -	1	82	175	135	48	80	44	20	31	38	37	60

Shares Outstanding	- -	- -	20	20	41	41	46	49	50	50	50	70	76
Diluted Weighted Avg Shares	- -	- -	20	20	25	41	46	47	49	50	50	63	75
Basic Weighted Avg Shares	- -	- -	20	20	25	41	46	47	49	50	50	63	74
Revenue per Share	4.84	5.38	- -	0.1	0.29	0.22	0.13	0.14	0.16	0.22	0.26	0.4	0.44
EBITDA per Share	0.08	0.3	-0.03	-0.04	-0.12	-0.04	-0.05	-0.08	- -	-0.11	-0.05	0.15	0.1
Operating Income per Share	-0.61	-0.35	-0.05	-0.15	-0.15	-0.06	-0.08	-0.1	-0.02	-0.13	-0.07	0.14	0.08
Basic EPS, GAAP	-0.96	-1.4	-0.08	-0.19	0.15	-0.06	-0.02	-0.16	-0.32	-0.34	-0.16	0.09	0.03
Basic EPS from Cont Ops	-0.96	-1.4	-0.08	-0.19	0.13	-0.07	-0.02	-0.17	-0.32	-0.35	-0.17	0.09	0.03
Diluted EPS, GAAP	-0.96	-1.4	-0.08	-0.19	0.15	-0.06	-0.02	-0.16	-0.32	-0.34	-0.16	0.09	0.03
Diluted EPS from Cont Ops	-0.96	-1.4	-0.08	-0.19	0.13	-0.07	-0.02	-0.17	-0.32	-0.35	-0.17	0.09	0.03
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.38	-0.47	-0.04	-0.05	-0.04	-0.02	-0.09	-0.06	-0.03	-0.17	-0.16	0.05	-0.01
Free Cash Flow per Basic Share	-0.6	-0.47	-0.04	-0.11	-0.1	-0.07	-0.13	-0.09	-0.04	-0.18	-0.16	0.01	-0.01
Cash & Equivalents per Share	0.58	0.07	- -	0.08	0.06	0.03	0.09	0.06	0.07	0.08	0.05	0.09	0.09
Book Value per Share	-21.65	-21.83	-0.14	-0.34	-0.5	-0.36	-0.34	-0.49	-0.79	-1.12	-1.28	-0.92	-0.76
Tangible Book Value per Share	20.59	18.11	0.23	0.61	0.19	0.1	0.3	0.31	0.26	0.08	-0.09	0.15	0.22

Aoxing Pharmaceutical Company, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)